167 related articles for article (PubMed ID: 6873479)
1. Current status of an oral B subunit whole cell cholera vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim A; Sack DA; Holmgren J
Dev Biol Stand; 1983; 53():73-9. PubMed ID: 6873479
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
4. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
5. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
[TBL] [Abstract][Full Text] [Related]
6. The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit.
Lewis DJ; Novotny P; Dougan G; Griffin GE
Eur J Immunol; 1991 Sep; 21(9):2087-94. PubMed ID: 1889459
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
Ahmed T; Arifuzzaman M; Lebens M; Qadri F; Lundgren A
Vaccine; 2009 Dec; 28(2):422-9. PubMed ID: 19837094
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
[TBL] [Abstract][Full Text] [Related]
9. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.
Quiding M; Nordström I; Kilander A; Andersson G; Hanson LA; Holmgren J; Czerkinsky C
J Clin Invest; 1991 Jul; 88(1):143-8. PubMed ID: 1905327
[TBL] [Abstract][Full Text] [Related]
10. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of safety and effects on the oral whole cell/recombinant B subunit cholera vaccine in university students and workers].
Shi NM; Luo FJ; Li SM; Bai YH; Qu Y; Song X
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):192-5. PubMed ID: 20356556
[TBL] [Abstract][Full Text] [Related]
12. Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.
Lycke N; Lindholm L; Holmgren J
Clin Exp Immunol; 1985 Oct; 62(1):39-47. PubMed ID: 4064375
[TBL] [Abstract][Full Text] [Related]
13. Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.
Ganguly R; Clem LW; Bencić Z; Sinha R; Sakazaki R; Waldman RH
Bull World Health Organ; 1975; 52(3):323-30. PubMed ID: 779998
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
15. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
17. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
18. Current status of cholera and rise of novel mucosal vaccine.
Yamamoto T
Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
[TBL] [Abstract][Full Text] [Related]
19. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
[TBL] [Abstract][Full Text] [Related]
20. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
Jertborn M; Svennerholm AM; Holmgren J
J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
